Dare Bioscience Inc DARE

Healthcare Biotechnology

Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.

NDAQ:DARE - Post by User

Dare Bioscience Inc

<< Previous

Bullboard Posts

Next >>

(431)
•••

Post by Chefboy69on Dec 06, 2021 9:23pm

162 Views

Post# 34204583

FDA announcement in the morning

i have been loaded up for months just waiting for tomorrow

Good luck everyone

(if Mil_man 54 shows up, do not be surprised. HE's just upset I shed light on his motives on the board he posts on)

just iggie him

<< Previous

Bullboard Posts

Next >>

A Canadian mineral company at the crossroads of electrification and defense